Multicentric osteolytic syndromes represent a phenotypic spectrum defined by defective collagen remodeling

de Vos, I.J.H.M. and Wong, A.S.W. and Welting, T.J.M. and Coull, B.J. and van Steensel, M.A.M. (2019) Multicentric osteolytic syndromes represent a phenotypic spectrum defined by defective collagen remodeling. American Journal of Medical Genetics, Part A, 179 (8). pp. 1652-1664. ISSN 1552-4825

Text (Defective Collagen Remodelling Spectrum Review_Revision1_Minor edits)
Defective_Collagen_Remodelling_Spectrum_Review_Revision1_Minor_edits.pdf - Accepted Version
Available under License Creative Commons Attribution-NonCommercial.
Download (548kB)

Abstract

Frank-Ter Haar syndrome (FTHS), Winchester syndrome (WS), and multicentric osteolysis, nodulosis, and arthropathy (MONA) are ultra-rare multisystem disorders characterized by craniofacial malformations, reduced bone density, skeletal and cardiac anomalies, and dermal fibrosis. These autosomal recessive syndromes are caused by homozygous mutation or deletion of respectively SH3PXD2B (SH3 and PX Domains 2B), MMP14 (matrix metalloproteinase 14), or MMP2. Here, we give an overview of the clinical features of 63 previously reported patients with an SH3PXD2B, MMP14, or MMP2 mutation, demonstrating considerable clinical overlap between FTHS, WS, and MONA. Interestingly, the protein products of SH3PXD2B, MMP14, and MMP2 directly cooperate in collagen remodeling. We review animal models for these three disorders that accurately reflect the major clinical features and likewise show significant phenotypical similarity with each other. Furthermore, they demonstrate that defective collagen remodeling is central in the underlying pathology. As such, we propose a nosological revision, placing these SH3PXD2B, MMP14, and MMP2 related syndromes in a novel “defective collagen-remodelling spectrum (DECORS)”. In our opinion, this revised nosology better reflects the central role for impaired collagen remodeling, a potential target for pharmaceutical intervention.